Harris · Atherosclerosis 2012 · Cross-sectional cohort study · n=3196

Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study.

Cited 145 times in the scientific literature.

Level 4 - case-series / case-control

Cross-sectional observational and heritability analysis within established cohorts

PubMed 22727409 · doi:10.1016/j.atherosclerosis.2012.05.030 · record verified 2026-08-30

What was done

Red blood cell fatty acid composition was analyzed by gas chromatography in 3,196 samples collected between 2005 and 2008 from participants in the Framingham Heart Study (Offspring cohort Examination 8 and Omni cohort Examination 3). Multivariable regression models were used to evaluate clinical correlates of the omega-3 index (erythrocyte EPA plus DHA percentage) and to estimate its heritability.

What was found

The mean (SD) omega-3 index was 5.6% (1.7%). The fully adjusted multivariable model explained 73% of total variability, with major contributions from dietary EPA plus DHA intake (25%), heritability (24%), and fish oil supplementation (15%). Significant direct correlates were age, female sex, higher education, fish oil supplementation, dietary EPA plus DHA intake, aspirin use, lipid pharmacotherapy, and LDL-cholesterol. Significant inverse correlates were Offspring cohort membership, heart rate, waist girth, triglycerides, and smoking.

Why it matters

This study quantifies the primary drivers of omega-3 index variability in a community population, showing that genetic heritability accounts for roughly a quarter of the variance alongside dietary and supplemental intake.

Limits

The study is cross-sectional, precluding causal inferences. The abstract does not report numerical effect sizes, regression coefficients, or confidence intervals for the individual clinical correlates.

Cited by